Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.31 |
| ▸ | CCNC | P24863 | 1/20 | 0.31 |
| ▸ | CDK8 | P49336 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.30 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | CTSB | P07858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21881933 | 0.86 | TRPA1 (0.35) | CYP2A6TRPA1SIRT3TDP1ALOX5 | |
| SCHEMBL14822507 | 0.86 | TRPA1 (0.35) | CYP2A6TRPA1SIRT3TDP1ALOX5 | |
| SCHEMBL13043156 | 0.81 | TRPA1 (0.33) | TRPA1SIRT3TDP1ALOX5CCNC | |
| SCHEMBL24093984 | 0.80 | TRPA1 (0.30) | TRPA1 | |
| SCHEMBL25398653 | 0.77 | — | — | |
| SCHEMBL25752586 | 0.76 | SIRT3 (0.37) | CYP2A6TRPA1SIRT3TDP1ALOX5 | |
| SCHEMBL9000344 | 0.74 | TRPA1 (0.33) | CYP2A6TRPA1SIRT3TDP1ALOX5 | |
| SCHEMBL19159158 | 0.74 | KDM4E (0.40) | — | |
| SCHEMBL26508276 | 0.73 | SIRT3 (0.35) | CYP2A6TRPA1SIRT3TDP1ALOX5 | |
| SCHEMBL18630229 | 0.73 | TRPA1 (0.33) | TRPA1SIRT3TDP1ALOX5CCNC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200048199-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DEVICE HAVING THE COMPOUND | LG DISPLAY CO., LTD. (KR) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200048199-A1 | ORGANIC COMPOUND, AND ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DEVICE HAVING THE COMPOUND | OCIAD1, OCIAD2, FZD7 | CYP2A6 1101/4885TRPA1 85/4885SIRT3 3216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.